Ancillary and supportive care in chronic graft-versus-host disease

Best Practice and Research: Clinical Haematology

Volumn 21, Issue 2, 2008, Pages 291-307

  Couriel, Daniel R ^a  

^a Tennessee Oncology   (United States)

Author keywords

chronic GVHD; hematopoietic cell transplantation; late effects

Indexed keywords

ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; ANTIINFECTIVE AGENT; BETAMETHASONE DIPROPIONATE; CALCINEURIN INHIBITOR; CEVIMELINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLOBETASOL; CORTICOSTEROID; DESONIDE; DEXAMETHASONE; FLUORIDE; HYDROCORTISONE; HYDROQUINONE; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; LIDOCAINE; NARCOTIC ANALGESIC AGENT; OXYGEN; PILOCARPINE; PIMECROLIMUS; PRAMOCAINE; PREDNISOLONE; RETINOIC ACID; SEROTONIN UPTAKE INHIBITOR; STEROID; TACROLIMUS; TRIAMCINOLONE; ULOBETASOL PROPIONATE; UNINDEXED DRUG;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BACTERIAL INFECTION; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL FEATURE; CLINICAL PROTOCOL; CLINICAL TRIAL; DEBRIDEMENT; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG POTENCY; DRUG RESPONSE; DRUG SAFETY; DRY EYE; ENDOCARDITIS; EVIDENCE BASED MEDICINE; EYE DISEASE; EYE SURGERY; GYNECOLOGICAL EXAMINATION; HISTOPATHOLOGY; HUMAN; HYPERBARIC OXYGEN; IMMUNOPATHOLOGY; MONOTHERAPY; MOUTH DISEASE; MYCOSIS; OCCUPATIONAL THERAPY; OXYGEN THERAPY; PATIENT ASSESSMENT; PATIENT CARE; PERSONAL HYGIENE; PHOTOTHERAPY; PHYSIOTHERAPY; PRIORITY JOURNAL; PROGNOSIS; PUVA; RATING SCALE; REVIEW; SALIVARY GLAND DISEASE; SKIN APPENDAGE DISEASE; SKIN DISEASE; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; VAGINA DISEASE; VIRUS INFECTION; VISUAL SYSTEM EXAMINATION; VULVA DISEASE;

ADMINISTRATION, TOPICAL; BACTERIAL INFECTIONS; CHRONIC DISEASE; EVIDENCE-BASED MEDICINE; GRAFT VS HOST DISEASE; HUMANS; MUCOSITIS; PALLIATIVE CARE; SKIN DISEASES; VIRUS DISEASES;

EID: 44249109747     PISSN: 15216926     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.beha.2008.02.014     Document Type: Review

References (74)

1. Couriel D., Carpenter P.A., Cutler C., et al. Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report. Biology of Blood and Marrow Transplantation 12 4 (2006 Apr) 375-396
2. Filipovich A.H., Weisdorf D., Pavletic S., et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biology of Blood and Marrow Transplantation 11 12 (2005 Dec) 945-956
3. Kitajima T., and Imamura S. Graft-versus-host reaction enhanced by ultraviolet radiation. Archives of Dermatological Research 285 8 (1993) 499-501
4. Vogelsang G.B., Wolff D., Altomonte V., et al. Treatment of chronic graft-versus-host disease with ultraviolet irradiation and psoralen (PUVA). Bone Marrow Transplantation 17 6 (1996 Jun) 1061-1067
5. Leiter U., Kaskel P., Krahn G., et al. Psoralen plus ultraviolet-A-bath photochemotherapy as an adjunct treatment modality in cutaneous chronic graft versus host disease. Photodermatology Photoimmunology and Photomedicine 18 4 (2002 Aug) 183-190
6. Hymes S.R., Morison W.L., Farmer E.R., et al. Methoxsalen and ultraviolet A radiation in treatment of chronic cutaneous graft-versus-host reaction. Journal of the American Academy of Dermatology 12 1 Pt 1 (1985 Jan) 30-37
7. Wetzig T., Sticherling M., Simon J.C., et al. Medium dose long-wavelength ultraviolet A (UVA1) phototherapy for the treatment of acute and chronic graft-versus-host disease of the skin. Bone Marrow Transplantation 35 5 (2005 Mar) 515-519
8. Enk C.D., Elad S., Vexler A., et al. Chronic graft-versus-host disease treated with UVB phototherapy. Bone Marrow Transplantation 22 12 (1998 Dec) 1179-1183
9. Grundmann-Kollmann M., Martin H., Ludwig R., et al. Narrowband UV-B phototherapy in the treatment of cutaneous graft versus host disease. Transplantation 74 11 (2002 Dec 15) 1631-1634
10. Elad S., Or R., Resnick I., et al. Topical tacrolimus-a novel treatment alternative for cutaneous chronic graft-versus-host disease. Transplant International 16 9 (2003 Sep) 665-670
11. Ziemer M., Gruhn B., Thiele J.J., et al. Treatment of extensive chronic cutaneous graft-versus-host disease in an infant with topical pimecrolimus. Journal of the American Academy of Dermatology 50 6 (2004 Jun) 946-948
12. Smith A.P.S., and Fife C.E. 'Advanced therapeutics: the biochemistry and biophysical basis of wound products'. In: Sheffield P.J. (Ed). Wound care practice (2004), Best Publishing Company, Flagstaff AZ
13. Dimeo F., Bertz H., Finke J., et al. An aerobic exercise program for patients with haematological malignancies after bone marrow transplantation. Bone Marrow Transplantation 18 6 (1996 Dec) 1157-1160
14. Dimeo F.C., Stieglitz R.D., Novelli-Fischer U., et al. Effects of physical activity on the fatigue and psychologic status of cancer patients during chemotherapy. Cancer 85 10 (1999 May 15) 2273-2277
15. Mello M., Tanaka C., and Dulley F.L. Effects of an exercise program on muscle performance in patients undergoing allogeneic bone marrow transplantation. Bone Marrow Transplantation 32 7 (2003 Oct) 723-728
16. Woo S.B., Lee S.J., and Schubert M.M. Graft-vs.-host disease. Critical Reviews in Oral Biology and Medicine 8 2 (1997) 201-216
17. Voute A.B., Schulten E.A., Langendijk P.N., et al. Fluocinonide in an adhesive base for treatment of oral lichen planus. A double-blind, placebo-controlled clinical study. Oral Surgery Oral Medicine Oral Pathology 75 2 (1993 Feb) 181-185
18. Eckardt A., Starke O., Stadler M., et al. Severe oral chronic graft-versus-host disease following allogeneic bone marrow transplantation: highly effective treatment with topical tacrolimus. Oral Oncology 40 8 (2004 Sep) 811-814
19. Sanchez A.R., Sheridan P.J., and Rogers R.S. Successful treatment of oral lichen planus-like chronic graft-versus-host disease with topical tacrolimus: a case report. Journal of Periodontology 75 4 (2004 Apr) 613-619
20. Wolff D., Anders V., Corio R., et al. Oral PUVA and topical steroids for treatment of oral manifestations of chronic graft-vs.-host disease. Photodermatology Photoimmunology and Photomedicine 20 4 (2004 Aug) 184-190
21. Nagler R., Marmary Y., Krausz Y., et al. Major salivary gland dysfunction in human acute and chronic graft-versus-host disease (GVHD). Bone Marrow Transplantation 17 2 (1996 Feb) 219-224
22. Schubert M.M., Sullivan K.M., Morton T.H., et al. Oral manifestations of chronic graft-v-host disease. Archives of Internal Medicine 144 8 (1984 Aug) 1591-1595
23. Nicolatou-Galitis O., Kitra V., Van Vliet-Constantinidou C., et al. The oral manifestations of chronic graft-versus-host disease (cGVHD) in paediatric allogeneic bone marrow transplant recipients. Journal of Oral Pathology and Medicine 30 3 (2001 Mar) 148-153
24. Treister N., Woo S., Lehmann L.E., et al. Oral chronic graft-versus-host disease in pediatric patients following hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation 11 (2005) 721-731
25. Schubert M.M., and Sullivan K.M. Recognition, incidence, and management of oral graft-versus-host disease. NCI Monographs 9 (1990) 135-143
26. Nagler R.M., and Nagler A. Major salivary gland involvement in graft-versus-host disease: considerations related to pathogenesis, the role of cytokines and therapy. Cytokines, Cellular and Molecular Therapy 5 4 (1999 Dec) 227-232
27. Nagler R.M., and Nagler A. Sialometrical and sialochemical analysis of patients with chronic graft-versus-host disease-a prolonged study. Cancer Investigation 21 1 (2003) 34-40
28. Dajani A.S., Taubert K.A., Wilson W., et al. Prevention of bacterial endocarditis: recommendations by the American Heart Association. Journal of the American Dental Association 128 8 (1997 Aug) 1142-1151
29. Calissendorff B., el Azazi M., and Lonnqvist B. Dry eye syndrome in long-term follow-up of bone marrow transplanted patients. Bone Marrow Transplantation 4 6 (1989 Nov) 675-678
30. Jack M.K., Jack G.M., Sale G.E., et al. Ocular manifestations of graft-v-host disease. Archives of Ophthalmology 101 7 (1983 Jul) 1080-1084
31. Hill J.C. Slow-release artificial tear inserts in the treatment of dry eyes in patients with rheumatoid arthritis. British Journal of Ophthalmology 73 2 (1989 Feb) 151-154
32. Tanei R., Ohta Y., Ishihara S., et al. Transfusion-associated graft-versus-host disease: an in situ hybridization analysis of the infiltrating donor-derived cells in the cutaneous lesion. Dermatology 199 1 (1999) 20-24
33. Hart D.E., Simko M., and Harris E. How to produce moisture chamber eyeglasses for the dry eye patient. Journal of the American Optometric Association 65 7 (1994 Jul) 517-522
34. Frucht-Pery J., Sagi E., Hemo I., et al. Efficacy of doxycycline and tetracycline in ocular rosacea. American Journal of Ophthalmology 116 1 (1993 Jul 15) 88-92
35. Cosar C.B., Cohen E.J., Rapuano C.J., et al. Tarsorrhaphy: clinical experience from a cornea practice. Cornea 20 8 (2001 Nov) 787-791
36. Rosenthal P., Cotter J.M., and Baum J. Treatment of persistent corneal epithelial defect with extended wear of a fluid-ventilated gas-permeable scleral contact lens. American Journal of Ophthalmology 130 1 (2000 Jul) 33-41
37. Punctal occlusion for the dry eye. Three-year revision. American Academy of Ophthalmology. Ophthalmology 104 9 (1997 Sep) 1521-1524
38. Altan-Yaycioglu R., Gencoglu E.A., Akova Y.A., et al. Silicone versus collagen plugs for treating dry eye: results of a prospective randomized trial including lacrimal scintigraphy. American Journal of Ophthalmology 140 1 (2005 Jul) 88-93
39. Hutnik C.M., and Probst L.E. Argon laser punctal therapy versus thermal cautery for the treatment of aqueous deficiency dry eye syndrome. Canadian Journal of Ophthalmology 33 7 (1998 Dec) 365-372
40. Marsh P., and Pflugfelder S.C. Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjogren syndrome. Ophthalmology 106 4 (1999 Apr) 811-816
41. Robinson M.R., Lee S.S., Rubin B.I., et al. Topical corticosteroid therapy for cicatricial conjunctivitis associated with chronic graft-versus-host disease. Bone Marrow Transplantation 33 10 (2004 May) 1031-1035
42. Sall K., Stevenson O.D., Mundorf T.K., et al. Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group. Ophthalmology 107 4 (2000 Apr) 631-639
43. Kojima T., Ishida R., Dogru M., et al. The effect of autologous serum eyedrops in the treatment of severe dry eye disease: a prospective randomized case-control study. American Journal of Ophthalmology 139 2 (2005 Feb) 242-246
44. Ogawa Y., Okamoto S., Mori T., et al. Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease. Bone Marrow Transplantation 31 7 (2003 Apr) 579-583
45. Corson S.L., Sullivan K., and Batzer F. Gynecologic manifestations of chronic graft-versus-host disease. Obstetrics and Gynecology 60 4 (1982 Oct) 488-492
46. Schubert M.A., Sullivan K.M., Schubert M.M., et al. Gynecological abnormalities following allogeneic bone marrow transplantation. Bone Marrow Transplantation 5 6 (1990 Jun) 425-430
47. Spiryda L.B., Laufer M.R., Soiffer R.J., et al. Graft-versus-host disease of the vulva and/or vagina: diagnosis and treatment. Biology of Blood and Marrow Transplantation 9 12 (2003 Dec) 760-765
48. Anderson M., Kutzner S., and Kaufman R.H. Treatment of vulvovaginal lichen planus with vaginal hydrocortisone suppositories. Obstetrics and Gynecology 100 2 (2002 Aug) 359-362
49. Vogelsang G.B. How I treat chronic graft-versus-host disease. Blood 97 5 (2001 Mar 1) 1196-1201
50. Roy V., Ochs L., and Weisdorf D. Late infections following allogeneic bone marrow transplantation: suggested strategies for prophylaxis. Leukemia and Lymphoma 26 1-2 (1997 Jun) 1-15
51. Wingard J.R., Vogelsang G.B., and Deeg H.J. Stem cell transplantation: supportive care and long-term complications. Hematology (The American Society Hematology Education Program) (2002) 422-444
52. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. MMWR. Recommendations and Reports 49 RR-10 (2000 Oct) 1-125 CE1-7
53. Haddad P.A., Repka T.L., and Weisdorf D.J. Penicillin-resistant Streptococcus pneumoniae septic shock and meningitis complicating chronic graft versus host disease: a case report and review of the literature. American Journal of Medicine 113 2 (2002 Sep 1) 152-155
54. Kulkarni S., Powles R., Treleaven J., et al. Chronic graft versus host disease is associated with long-term risk for pneumococcal infections in recipients of bone marrow transplants. Blood 95 12 (2000 Jun 15) 3683-3686
55. Molrine D.C., Antin J.H., Guinan E.C., et al. Donor immunization with pneumococcal conjugate vaccine and early protective antibody responses following allogeneic hematopoietic cell transplantation. Blood 101 3 (2003 Feb 1) 831-836
56. Nachman S., Kim S., King J., et al. Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants with human immunodeficiency virus type 1 infection. Pediatrics 112 1 Pt 1 (2003 Jul) 66-73
57. Shinefield H., Black S., Ray P., et al. Efficacy, immunogenicity and safety of heptavalent pneumococcal conjugate vaccine in low birth weight and preterm infants. Pediatric Infectious Disease Journal 21 3 (2002 Mar) 182-186
58. Winston D.J., Antin J.H., Wolff S.N., et al. A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation. Bone Marrow Transplantation 28 2 (2001 Jul) 187-196
59. Cordonnier C., Chevret S., Legrand M., et al. Should immunoglobulin therapy be used in allogeneic stem-cell transplantation? A randomized, double-blind, dose effect, placebo-controlled, multicenter trial. Annals of Internal Medicine 139 1 (2003 Jul 1) 8-18
60. Intravenous immunoglobulin for the prevention of infection in chronic lymphocytic leukemia. A randomized, controlled clinical trial. cooperative group for the study of immunoglobulin in chronic lymphocytic leukemia. The New England Journal of Medicine 319 14 (1988 Nov 6) 902-907
61. Intravenous immune globulin for the prevention of bacterial infections in children with symptomatic human immunodeficiency virus infection. The National Institute of Child Health and Human Developments Intravenous Immunoglobulin Study Group. The New England Journal of Medicine 325 2 (1991 Aug 11) 73-80
62. Magny J.F., Bremard-Oury C., Brault D., et al. Intravenous immunoglobulin therapy for prevention of infection in high-risk premature infants: report of a multicenter, double-blind study. Pediatrics 88 3 (1991 Oct) 437-443
63. Leather H.L., and Wingard J.R. Prophylaxis, empirical therapy, or pre-emptive therapy of fungal infections in immunocompromised patients: which is better for whom?. Current Opinion in Infectious Diseases 15 4 (2002 Aug) 369-375
64. Ullmann A.J., Lipton J.H., Vesole D.H., et al. Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. The New England Journal of Medicine 356 4 (2007 Jan 25) 335-347
65. Souza J.P., Boeckh M., Gooley T.A., et al. High rates of Pneumocystis carinii pneumonia in allogeneic blood and marrow transplant recipients receiving dapsone prophylaxis. Clinical Infectious Diseases 29 6 (1999) 1467-1471
66. Lyytikainen O., Ruutu T., Volin L., et al. Late onset Pneumocystis carinii pneumonia following allogeneic bone marrow transplantation. Bone Marrow Transplantation 17 6 (1996 Jun) 1057-1059
67. Koc S., Leisenring W., Flowers M.E., et al. Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone. Blood 100 1 (2002 Jul 1) 48-51
68. Perren T.J., Powles R.L., Easton D., et al. Prevention of herpes zoster in patients by long-term oral acyclovir after allogeneic bone marrow transplantation. American Journal of Medicine 85 2A (1988 Sep 29) 99-101
69. Kanda Y., Mineishi S., Saito T., et al. Long-term low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation 28 7 (2001 Nov) 689-692
70. Boeckh M.K.H.W., Flowers M.E., Meyers J.D., et al. Long-term acyclovir for prevention of varicella zoster virus disease after allogeneic hematopoietic cell transplantation - a randomized double-blind placebo-controlled study. Blood 107 5 (2006) 1800-1805
71. Yoo J.H., Lee D.G., Choi S.M., et al. Infectious complications and outcomes after allogeneic hematopoietic stem cell transplantation in Korea. Bone Marrow Transplantation 34 6 (2004 Oct) 497-504
72. Boeckh M., Leisenring W., Riddell S.R., et al. Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity. Blood 101 2 (2003 Feb 15) 407-414
73. Sintchenko V., Gilbert G.L., Coiera E., et al. Treat or test first? Decision analysis of empirical antiviral treatment of influenza virus infection versus treatment based on rapid test results. Journal of Clinical Virology 25 1 (2002 Jul) 15-21
74. Rothberg M.B., Bellantonio S., and Rose D.N. Management of influenza in adults older than 65 years of age: cost-effectiveness of rapid testing and antiviral therapy. Annals of Internal Medicine 139 5 Pt 1 (2003 Sep 2) 321-329